Safety and Efficacy of Punctal Plug Insertion in Patients With Dry Eye
NCT01684436 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2019-04-17
Summary
This study will access changes in tear protein levels and symptoms of dry eye following insertion of a punctal plug.
Conditions
- Dry Eye
Interventions
- DEVICE
-
Punctal Plug
Punctal plugs inserted into the study eye on Day 1.
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Principal Investigators
-
Medical Director · Allergan
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-01
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
Countries
- Singapore
Study Locations
More Related Trials
-
Comparison of Efficacy Between 100% Platelet-rich Plasma and 100% Serum Eye Drops in Dry Eye Disease
NCT04683796 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03846453 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes
NCT03334539 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users
NCT05306561 ·Status: RECRUITING ·Phase: NA
-
Assessing the Impact of Tixel Treatment of Periorbital Wrinkles on Dry Eye Symptoms and Signs
NCT04730336 ·Status: COMPLETED ·Phase: NA
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00404131 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
NCT01558999 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
NCT01733992 ·Status: COMPLETED ·Phase: PHASE1
-
Randomised Research Comparing Acupuncture, Herbal Treatment and Artificial Tear Eye Drops in Dry Eye
NCT02219204 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
NCT01163643 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome
NCT02774707 ·Status: UNKNOWN
-
Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser Epithelial Keratomileusis (LASEK) Surgery
NCT06120348 ·Status: RECRUITING ·Phase: NA
-
A Study of RX-10045 in the Treatment of Dry Eye Disease
NCT01675570 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
Study of OT202 in Treating Moderate to Severe Dry Eye
NCT06435182 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation on Medical Management of Dry Eye Patients
NCT01942226 ·Status: COMPLETED
-
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
NCT00037661 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects
NCT02380248 ·Status: COMPLETED ·Phase: NA
-
Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT04201574 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the TearCare System in Dry Eye Disease
NCT03588624 ·Status: COMPLETED ·Phase: NA
-
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
NCT02435914 ·Status: COMPLETED ·Phase: PHASE2